Beijing’s global pharmaceutical push is following a playbook seen in rare earths, semiconductors and electric vehicles, US lawmakers said on Wednesday, as concerns grow over the United States’ reliance on Chinese drug ingredients.
“China is cornering the market on our medicines – from the supply of generic drugs that Americans depend on every day, to the cutting-edge biotech pipeline that will determine who leads medicine in the years and decades ahead,” said John Moolenaar, the chair of the…
